Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator

There has been no extensive study to compare the efficacy between rituximab originator (Mabthera®) and its biosimilar (Truxima®) for microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Here, we investigated the clinical effects of rituximab on poor outcomes of MPA and GPA in K...

Full description

Saved in:
Bibliographic Details
Published inYonsei medical journal Vol. 61; no. 8; pp. 712 - 719
Main Authors Kwon, Hyeok Chan, Kim, Minyoung Kevin, Song, Jason Jungsik, Park, Yong-Beom, Lee, Sang-Won
Format Journal Article
LanguageEnglish
Published Yonsei University College of Medicine 01.08.2020
연세대학교의과대학
Subjects
Online AccessGet full text

Cover

Loading…